|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
132,343,505 |
|
|
Direct
Value |
$200,615,941 |
|
|
Indirect Value
|
$516,931,851 |
|
|
Total
Shares |
136,028,202 |
|
|
Total
Value |
$717,547,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
Percentage
Gain/Loss : |
-48.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-08-09 |
116,104,879 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
272 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,911,250 |
|
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
340,000 |
|
- |
|
PGEN |
Precigen Inc |
Chief Executive OfficerOfficer |
|
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,375,298 |
|
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2003-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
615,050 |
1,048,191 |
|
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2003-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,411,600 |
112,890 |
|
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2005-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
1,056,191 |
0 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-02-09 |
4 |
A |
$23.40 |
$3,588,507 |
I/I |
153,355 |
153,353 |
|
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-05-18 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
366,246 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-17 |
4 |
B |
$2.46 |
$231,486 |
I/I |
94,100 |
170,800 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-18 |
4 |
B |
$2.42 |
$8,470 |
I/I |
3,500 |
174,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-21 |
4 |
B |
$2.46 |
$30,750 |
I/I |
12,500 |
186,800 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-22 |
4 |
B |
$2.46 |
$43,296 |
I/I |
17,600 |
204,400 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-22 |
4 |
B |
$12.30 |
$49,348 |
I/I |
4,012 |
512,762 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-23 |
4 |
B |
$2.49 |
$16,683 |
I/I |
6,700 |
211,100 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-23 |
4 |
B |
$12.97 |
$162,125 |
I/I |
12,500 |
525,262 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-24 |
4 |
B |
$13.17 |
$140,827 |
I/I |
10,693 |
535,955 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-24 |
4 |
B |
$2.50 |
$233,250 |
I/I |
93,300 |
304,400 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-25 |
4 |
B |
$13.48 |
$103,756 |
I/I |
7,697 |
543,652 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-25 |
4 |
B |
$2.50 |
$277,250 |
I/I |
110,900 |
415,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-28 |
4 |
B |
$15.07 |
$210,829 |
I/I |
13,990 |
557,642 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-28 |
4 |
B |
$2.56 |
$153,600 |
I/I |
60,000 |
475,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-29 |
4 |
B |
$2.60 |
$59,800 |
I/I |
23,000 |
498,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-29 |
4 |
B |
$15.00 |
$189,315 |
I/I |
12,621 |
570,263 |
2.25 |
- |
|
272 Records found
|
|
Page 1 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|